PHS
ZBH icon

PFM Health Sciences’s Zimmer Biomet ZBH Stock Holding History

PFM Health Sciences’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-300,351
Closed -$39.6M – 94
2024
Q1 		$39.6M Buy
300,351
+187,695
+167% +$23.4M 1.86% 16
2023
Q4 		$13.7M Buy
+112,656
New +$12.6M 0.82% 40
2020
Q3 		– Sell
-185,288
Closed -$21.5M – 98
2020
Q2 		$21.5M Buy
+185,288
New +$21.4M 1.11% 34
2020
Q1 		– Sell
-455,906
Closed -$66.3M – 78
2019
Q4 		$66.3M Sell
455,906
-561,571
-55% -$77.5M 3.16% 9
2019
Q3 		$136M Sell
1,017,477
-182,982
-15% -$23.6M 4% 5
2019
Q2 		$137M Buy
1,200,459
+220,676
+23% +$25.8M 2.61% 6
2019
Q1 		$121M Buy
979,783
+281,105
+40% +$31.9M 2.68% 4
2018
Q4 		$70.4M Sell
698,678
-86,114
-11% -$9.68M 1.87% 20
2018
Q3 		$100M Sell
784,792
-136,662
-15% -$16.2M 1.47% 19
2018
Q2 		$99.7M Buy
921,454
+3,290
+0.4% +$358K 1.56% 12
2018
Q1 		$97.2M Buy
918,164
+223,112
+32% +$25.9M 1.98% 13
2017
Q4 		$81.4M Buy
+695,052
New +$78.6M 1.93% 17

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PFM Health Sciences's ZBH Position: Q2 2024 in Review

PFM Health Sciences sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 300,351 shares — an estimated $39.6M sold.

PFM Health Sciences first reported a position in ZBH in Q4 2017 and held it in 12 quarters. The position peaked at $137M in Q2 2019. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • PFM Health Sciences reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
  • PFM Health Sciences sold 300,351 Zimmer Biomet shares in Q2 2024, an estimated $39.6M.
  • PFM Health Sciences first reported a position in Zimmer Biomet in Q4 2017 and held it in 12 quarters.
  • PFM Health Sciences's Zimmer Biomet position peaked at $137M in Q2 2019.
  • 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on PFM Health Sciences's 13F filing for Q2 2024, filed 14 Aug 2024.